H+, K+-ATPase
2 drugs4
approved indications
2
Approved Drugs
2
Companies
5
Indications
0
Therapeutic Areas
Top Drugs
Unlock Full Target Intelligence PRO
✓ Competitive landscape by company (2 companies)
✓ All 2 approved drugs
✓ Therapeutic area breakdown
✓ Full indication list (5 indications)
✓ Patent cliff analysis
✓ Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo
Drugs by Company
PHATHOM PHARMACEUTICALS INC 1 drug
PHATHOM 1 drug
By Therapeutic Area
Other 2 drugs
Drugs by Company PRO
PHATHOM PHARMACEUTICALS INC 1 drug
PHATHOM 1 drug
By Therapeutic Area
Other 2 drugs
VOQUEZNA, VOQUEZNA DUAL PAK
Indications Treated
Erosive EsophagitisHeartburnNon-Erosive Gastroesophageal Reflux DiseaseHelicobacter Pylori InfectionHelicobacter pylori Infection
All Drugs Targeting H+, K+-ATPase
| Drug | Company | Approved | Indications | Therapeutic Area |
|---|---|---|---|---|
| VOQUEZNA | PHATHOM PHARMACEUTICALS INC | 2023 | 4 | |
| VOQUEZNA DUAL PAK | PHATHOM | 2022 | 1 |